IL17A and neoplasm: Furthermore, IL-17 is essential in certain therapeutic contexts, such as treatments involving PI3K pathway inhibitors and Toll-like receptor agonists in Lewis lung carcinoma, where it can sustain the anti-tumor effects during lung transplantation tumors (129).